Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,596.00
Bid: 1,595.50
Ask: 1,596.00
Change: -22.00 (-1.36%)
Spread: 0.50 (0.031%)
Open: 1,608.00
High: 1,615.00
Low: 1,594.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Shares Gain As Investors Await Fed Statement

Wed, 29th Jul 2015 15:59

LONDON (Alliance News) - London's main stock indices closed higher Wednesday, following a banquet of mostly positive UK corporate news for investors to chew over before a US Federal Reserve interest rate decision later in the evening.

The FTSE 100 closed up 1.2% at 6,631.00, and the FTSE 250 ended up 0.7% at 17,501.84, but the AIM All-Share closed flat at 749.16.

In mainland Europe, the CAC 40 in Paris ended up 0.8% and the DAX 30 in Frankfurt up 0.3%.

On Wall Street at the London close, the DJIA was trading up 0.6%, the S&P 500 was up 0.5%, while the Nasdaq Composite was up just 0.1%. Twitter shares were weighing on the Nasdaq index, down 13%, after its poorly received earnings report.

Investors will now be looking ahead to the US Fed's statement at 1900 BST in search for any clues about the timing of its first interest rate hike in nine years. Fed Chair Janet Yellen has indicated it would be appropriate to raise interest rates before year-end if the US economy evolves as expected, although she also has noted the timing of the first rate hike will be determined on a meeting-by-meeting basis.

It is largely expected that there will be no changes to monetary policy in Wednesday's statement but many market participants are looking at September as the month when the central bank will make its first move on interest rates.

"Any changes in the Fed's language will be heavily scrutinised for clues on whether the first hike could come at the next meeting in September. Naturally, different people will interpret the data very differently, probably dependent on their own bias and the result is big market swings and huge volatility. Especially given the proximity to the potential lift-off date," said Craig Erlam, senior market analyst at Oanda.

Analysts at Societe Generale anticipate the Fed decision to be uneventful, but they continue to maintain their central scenario of a September rate hike.

"Recent Fed speeches – particularly by Chair Yellen – suggest that the Fed has a strong desire to begin policy normalization and would like to start the process sooner rather than later. The hurdle with respect to domestic data appears to be quite low, and we believe that economic conditions will support a rate-hike decision by the September FOMC meeting," SocGen said. "If there is a delay, it will likely be driven by international or financial developments."

On the London Stock Exchange, GlaxoSmithKline reported half-year results at midday which drove its shares 3.1% higher. The pharmaceutical giant said it was on track to achieve its guidance for 2015, and said it remains confident in its outlook for 2016, as exceptional gains from asset sales helped boost profit in its first half.

It posted a pretax profit of GBP10.08 billion for the half year to end-June, increased from GBP1.89 billion a year before primarily, as a result of a GBP8.45 billion gain related to the sale of its oncology business to Novartis. Revenue rose to GBP11.51 billion from GBP11.17 billion.

British American Tobacco closed up 3.6% as it reported growth in profit in the first half of 2015, although revenue was hit by adverse exchange-rate movements, but BAT said it remains confident it will deliver an improved performance in the second half.

The FTSE 100-listed tobacco company reported a rise in pretax profit in the six months to June 30 to GBP3.5 billion from GBP2.6 billion, as revenue grew 2.4% at constant currency rates to GBP7 billion from GBP6.8 billion, but declined 5.9% to GBP6.4 billion at current rates. It said that revenue was driven by good pricing, but was hit by negative currency movements.

Barclays closed up 1.8% after it reported a jump in second-quarter net profit. Newly appointed Executive Chairman John McFarlane said the bank intends to pay a flat dividend for 2015 and wants to intensify efforts to cut risky assets in its non-core division.

Net profit increased to GBP1.15 billion in the quarter ended June 30, compared with GBP161 million in the corresponding period the prior year. The numbers included a GBP496 million gain on assets acquired from failed investment bank Lehman Brothers in 2008 and provisions of GBP850 million for customer compensation in the UK, among other charges.

Compass Group shares ended as the worst blue-chip performers down 5.3%, having hit their lowest level so far in 2015. The catering services and outsourcing company said it would book some restructuring charges related to its oil and gas-exposed business, which will flatten its margins for the 2015 financial year, though organic revenue held up in the third quarter.

Compass said it is delivering good operating efficiencies in its 2015 financial year and said its operating margin has improved in the first nine months. But Compass said that, in addition to the ongoing restructuring activities it has undertaken, it is pro-actively cutting costs in its offshore and remote business, which primarily serves the oil and gas and mining industries.

The incremental restructuring plan it will launch for this division will cost the company GBP20 million to GBP25 million a year in both 2015 and 2016 and, as a result, will mean its operating margin for the 2015 financial year to the end of September will be flat.

In the FTSE 250, Premier Farnell shares closed 16% lower, after hitting a six-year low. The technology products and services company warned it now expects its adjusted operating profit for its first half to be down 10% compared to the previous year, hit by slowing sales, challenging market conditions and the continued weakness of the euro. As a result, it now expects full-year adjusted operating profit to be down around 6% compared to the previous year.

Foxtons Group rose 7.4% after it said it expects to meet market expectations for its full year, as it posted a fall in pretax profit for its first half. Foxtons posted a pretax profit of GBP18.1 million for the half year to end-June, down from GBP23.1 million a year before, as revenue fell to GBP71.1 million from GBP72.8 million and administrative costs rose to GBP53.0 million from GBP49.8 million as a result of an increase in the company's branch network.

Greggs was the best mid-cap performer, however, ending up 8.5%. The bakery and food-to-go retailer reported a big rise in profit in the first half of 2015 and said it is confident it will deliver a good year of growth ahead of its previous expectations.

The company reported a jump in pretax profit in the 26 weeks to July 4 to GBP25.6 million from GBP8.6 million, as revenue grew to GBP398.4 million from GBP374.4 million. It said that revenue was boosted by an improvement in its products and due to investments it made into its shop estate. Profit also had been hit the year before by exceptional costs of GBP8.3 million.

Greggs share set a new 52-week high of 1,293.00p during trading and have more than doubled over the past year.

In the economic calendar Thursday, there are Japanese industrial production at 0050 BST, and German unemployment data at 0855 BST. The European Central Bank will publish its economic bulletin at 0900 BST, before European business sentiment survey results at 1000 BST. In the afternoon are German inflation data at 1300 BST, followed by US second quarter GDP at 1330 BST.

In the UK corporate calendar, there are half-year results from FTSE 100-listed AstraZeneca, Royal Dutch Shell, Centrica, Intercontinental Hotels Group, Schroders, BAE Systems, Rolls Royce Holdings, Royal Bank of Scotland Group, Smith & Nephew, Diageo, Intu Properties and Merlin Entertainments. There also are updates from a host of FTSE 250-constituents including Henderson Group, Inchcape and Laird. BT Group releases first quarter results, and Babcock International Group releases a trading update.

By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
20 Jun 2024 16:01

Industry groups back drugmakers' appeal in Zantac cancer lawsuits

June 20 (Reuters) - A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has received the backing of leading U.S. industry groups, including the United States Chamber of Commerce and Pharmaceutical Research and Manufacturers of America.

Read more
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.